Clinical trial
A Multicenter, Randomized, Study to Evaluate Safety and Efficacy After Treatment With the dNerva Lung Denervation System in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (AIRFLOW-4)
NCT07051707 is registered in ClinicalTrials.gov with Nuvaira, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Study to Evaluate Safety and Efficacy After Treatment With the dNerva Lung Denervation System in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (AIRFLOW-4)
- Lead sponsor
- Nuvaira, Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 24, 2026
- Completion date
- October 31, 2029
- Enrollment
- 200 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease, copd